Showing results (1401-1410 of 1,436) with videos related to
Sort By:
Pageof 144
The New England Journal of Medicine|December 8, 2015
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic LeukemiaJohn C Byrd, Bonnie Harrington, Susan O'Brien, et al.Leukemia|June 9, 2017
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLLJ R Brown, P Hillmen, S O'Brien, et al.Leukemia|November 7, 2023
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AMLGuillermo Garcia-Manero, Nikolai A Podoltsev, Megan Othus, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2021
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent LymphomaNathan H Fowler, Felipe Samaniego, Wojciech Jurczak, et al.Blood|April 7, 2021
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 resultsBijal D Shah, Michael R Bishop, Olalekan O Oluwole, et al.Human Mutation|July 12, 2019
Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variantsMelissa S Cline, Giulia Babbi, Sandra Bonache, et al.Journal of Magnetic Resonance Imaging : JMRI|May 2, 2022
Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerBenjamin C Musall, Beatriz E Adrada, Rosalind P Candelaria, et al.Journal of Magnetic Resonance Imaging : JMRI|February 15, 2021
Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast CancerBenjamin C Musall, Abeer H Abdelhafez, Beatriz E Adrada, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2021
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid LeukemiaPinkal M Desai, Janice Brown, Saar Gill, et al.Breast Cancer Research and Treatment|September 13, 2020
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)Abeer H Abdelhafez, Benjamin C Musall, Beatriz E Adrada, et al.Pageof 144